Marshall Wace, LLP Eucrates Biomedical Acquisition Corp. Transaction History

Marshall Wace, LLP

  • $90.8 Billion
  • Q3 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$9.76 - $9.85 $9,398 - $9,485
-963 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$9.75 - $9.85 $9,389 - $9,485
963 New
963 $9,000

About Eucrates Biomedical Acquisition Corp.

EUCR Quotes by TradingView
  • Ticker EUCR
  • Exchange
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,459,100
More about EUCR
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email